Coronary disease & ACSCohort study

Prognostic Impact of Recreational Drug Use on 1-Year Outcomes in NSTEMI and STEMI Patients

JACC AdvPublished

  • Addiction in Intensive Cardiac Care Units study
  • 39 French centers
  • prospective urinary testing
  • independent adjudication
  • propensity matching

Authors' conclusion

Recreational drug use was associated with increased 1-year MACE risk in ACS patients, particularly STEMI, supporting routine drug screening.

Study context

Population
Acute coronary syndrome (ACS) patients admitted to intensive cardiac care unitsACS patients, 13.5% had recreational drug detection
Participants
712 patients
Exposure
drug-positive vs drug-negative patients
Outcome
MACE, defined as cardiovascular death, nonfatal myocardial infarction, or stroke
Follow-up
1 year

Main finding

As reported in the abstract

Hazard ratio

2.70

95% CI 1.30–5.57

P = 0.013

By group

drug-positive vs drug-negative
HR 2.70 (95% CI 1.30–5.57); P = 0.013
Major adverse cardiovascular events (MACE) overall
7.0%

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
MACE in STEMI (subgroup) · 1 year — drug-positive vs drug-negative4.11 (1.60–10.5)P = 0.005
MACE in STEMI (subgroup) · 1 year — drug-positive vs drug-negative · propensity matching3.39 (1.19–9.62)P = 0.022

MACE in non-ST-elevation myocardial infarction (subgroup) · 1 year

Association not significant

Original publication

Prognostic Impact of Recreational Drug Use on 1-Year Outcomes in NSTEMI and STEMI Patients. JACC Adv. Published 23 January 2026. doi:10.1016/j.jacadv.2025.102574

Summarised from the published abstract; every number is checked against it